Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
13/09/2023 13:39
Sept 13 (Reuters) - Infinity Pharmaceuticals Inc
INFI.O :
* INFINITY PHARMACEUTICALS INC - ON SEPTEMBER 12, RECEIVED
DETERMINATION LETTER FROM NASDAQ
* INFINITY PHARMACEUTICALS INC - DETERMINATION LETTER
INDICATED
CO'S CONTINUED NON-COMPLIANCE WITH NASDAQ'S REQUIREMENT TO
MAINTAIN MINIMUM BID PRICE
* INFINITY PHARMACEUTICALS INC - DOES NOT PLAN TO REQUEST A
REVIEW
OF PANEL'S DECISION
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX